Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Jul;16(7):568-74.
doi: 10.1097/JGP.0b013e318172b406. Epub 2008 Jun 12.

Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials

Affiliations
Comparative Study

Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials

Jason Karlawish et al. Am J Geriatr Psychiatry. 2008 Jul.

Abstract

Objective: Among Alzheimer disease (AD) patients enrolled in a clinical trial, the authors assessed the ability of a standardized capacity assessment procedure to identify persons who are capable of giving their own informed consent.

Design: Cross-sectional interview.

Setting: Thirteen sites participating in a randomized and placebo controlled study of simvastatin for the treatment of mild to moderate AD.

Participants: Persons with mild to moderate AD and their study partners enrolled in the simvastatin clinical trial.

Measurements: Interviews to assess decision-making capacity using the MacArthur Competency Assessment Tool for Clinical Research (MacCAT-CR).

Results: Judges blinded to the subject's clinical status had a high rate of agreement on patients capable of giving their own informed consent (kappa = 0.73). The understanding subscale had the best receiver operator characteristic and an analysis of positive and negative predictive values over a range of hypothetical prevalences of incapacity to consent demonstrated the value of a range of understanding cut-points.

Conclusion: Among mild to moderate AD patients, enrolled in an actual clinical trial, these results suggest evidence based guidelines for using the MacCAT-CR understanding subscale to help guide judgments about whether a patient has the capacity to consent.

PubMed Disclaimer

Conflict of interest statement

Dr. Marson and Dr. Kim report no conflicts of interest.

References

    1. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001;344:1111–1116. - PubMed
    1. Schulz R, Mendelsohn AB, Haley WE, et al. End-of-life care and the effects of bereavement on family caregivers of persons with dementia. N Engl J Med. 2003;349:1936–1942. - PubMed
    1. Schulz R, O’Brien A, Bookwala J, et al. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist. 1995;35:771–791. - PubMed
    1. Gauthier S. Do we have a treatment for Alzheimer Disease? Yes Arch Neurol. 1999;56:738–739. - PubMed
    1. Pryse-Phillips W. Do we have drugs for dementia? No Arch Neurol. 1999;56:735–737. - PubMed